NanoViricides, Inc.
NNVC
$1.43
$0.096.72%
AMEX
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 7.11% | -26.89% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.23% | -35.00% | |||
| Operating Income | -9.23% | 35.00% | |||
| Income Before Tax | -9.34% | 35.16% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -9.34% | 35.16% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -9.34% | 35.16% | |||
| EBIT | -9.23% | 35.00% | |||
| EBITDA | -10.46% | 37.31% | |||
| EPS Basic | 0.58% | 38.99% | |||
| Normalized Basic EPS | 0.57% | 38.95% | |||
| EPS Diluted | 0.58% | 38.99% | |||
| Normalized Diluted EPS | 0.57% | 38.95% | |||
| Average Basic Shares Outstanding | 9.98% | 6.24% | |||
| Average Diluted Shares Outstanding | 9.98% | 6.24% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||